• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

麻醉拮抗剂长效给药系统II:纳曲酮从聚乳酸复合材料中的释放速率

Long acting delivery systems for narcotic antagonists II: release rates of naltrexone from poly(lactic acid) composites.

作者信息

Yolles S, Leafe T D, Woodland J H, Meyer F J

出版信息

J Pharm Sci. 1975 Feb;64(2):348-9. doi: 10.1002/jps.2600640239.

DOI:10.1002/jps.2600640239
PMID:1127596
Abstract

Parallel in vitro and in vivo release rates of tritiated naltrexone from poly(lactic acid) composites were studied. The in vitro release of naltrexone was 67% of the dose over a 35-day test period, while the in vivo release was only 24% within 70 days. Apparently, an exchange of the tritium for the hydrogen of the body water takes place, indicating that urinary excretion radioactivity is not a reliable measure for estimating the naltrexone released. Naltrexone-poly(lactic acid) composites showed effective blocking action to morphine in rats (24 days), dogs (29 days), monkeys (20 days), and mice (21 days).

摘要

研究了氚标记的纳曲酮从聚乳酸复合材料中的体外和体内平行释放率。在35天的测试期内,纳曲酮的体外释放量为剂量的67%,而在70天内的体内释放量仅为24%。显然,氚与体内水分中的氢发生了交换,这表明尿排泄放射性不是估计释放的纳曲酮的可靠指标。纳曲酮-聚乳酸复合材料对大鼠(24天)、狗(29天)、猴子(20天)和小鼠(21天)的吗啡显示出有效的阻断作用。

相似文献

1
Long acting delivery systems for narcotic antagonists II: release rates of naltrexone from poly(lactic acid) composites.麻醉拮抗剂长效给药系统II:纳曲酮从聚乳酸复合材料中的释放速率
J Pharm Sci. 1975 Feb;64(2):348-9. doi: 10.1002/jps.2600640239.
2
Naltrexone microspheres: in vitro release and effect on morphine analgesia in mice.纳曲酮微球:体外释放及其对小鼠吗啡镇痛的影响。
Acta Pharmacol Sin. 2001 Jun;22(6):530-3.
3
Development of injectable microcapsules for use in the treatment of narcotic addiction.
Natl Inst Drug Abuse Res Monogr Ser. 1975(4):19-20.
4
Chronic effects of select narcotic antagonists in mice.
Adv Biochem Psychopharmacol. 1973;8(0):417-25.
5
Sustained release of naltrexone from glyceride implants.
Natl Inst Drug Abuse Res Monogr Ser. 1976 Jan(4):27-32.
6
The structure-action relationship and kinetics of some naloxone and naltrexone derivatives.某些纳洛酮和纳曲酮衍生物的构效关系及动力学
Pharmacology. 1976;14(1):76-85. doi: 10.1159/000136582.
7
Limitations on the antagonistic actions of opioid antagonists.阿片类拮抗剂拮抗作用的局限性。
Fed Proc. 1982 May;41(7):2333-8.
8
In vivo and in vitro evaluation of a microencapsulated narcotic antagonist.微囊化麻醉拮抗剂的体内和体外评价
J Pharm Sci. 1976 Jun;65(6):847-50. doi: 10.1002/jps.2600650612.
9
Development of polylactic/glycolic acid delivery systems for use in treatment of narcotic addiction.
Natl Inst Drug Abuse Res Monogr Ser. 1976 Jan(4):13-8.
10
Antagonism of gut, but not central effects of morphine with quaternary narcotic antagonists.季铵类麻醉拮抗剂可拮抗吗啡对肠道的作用,但不能拮抗其对中枢的作用。
Eur J Pharmacol. 1982 Mar 12;78(3):255-61. doi: 10.1016/0014-2999(82)90026-7.

引用本文的文献

1
PLA micro- and nano-particles.聚乳酸微颗粒和纳米颗粒。
Adv Drug Deliv Rev. 2016 Dec 15;107:176-191. doi: 10.1016/j.addr.2016.05.020. Epub 2016 Jun 1.
2
Epidemiologic and molecular pathophysiology of chronic opioid dependence and the place of naltrexone extended-release formulations in its clinical management.慢性阿片类药物依赖的流行病学及分子病理生理学,以及纳曲酮缓释制剂在其临床管理中的地位。
Subst Abuse. 2012;6:115-33. doi: 10.4137/SART.S9031. Epub 2012 Sep 27.
3
RGD-modified poly(D,L-lactic acid) nanoparticles enhance tumor targeting of oridonin.
RGD 修饰的聚(D,L-乳酸)纳米粒增强冬凌草甲素的肿瘤靶向性。
Int J Nanomedicine. 2012;7:211-9. doi: 10.2147/IJN.S27581. Epub 2012 Jan 9.
4
Novel PEG-graft-PLA nanoparticles with the potential for encapsulation and controlled release of hydrophobic and hydrophilic medications in aqueous medium.新型 PEG 接枝 PLA 纳米粒子,具有在水介质中包封和控制释放疏水性和亲水性药物的潜力。
Int J Nanomedicine. 2011;6:1443-51. doi: 10.2147/IJN.S19765. Epub 2011 Jul 7.